Idiopathic disseminated cytomegalovirus infection
diseaseOn this page
Also known as idiopathic disseminated CMV infection
Summary
Idiopathic disseminated cytomegalovirus infection (MONDO:0018108) is a disease. A subtype of cytomegalovirus infection — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 29
Clinical features
Signs & symptoms
Clinical features (HPO)
29 HPO clinical features (Orphanet curated; top 29 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0002583 | Colitis | Very frequent (80-99%) |
| HP:0033431 | Cytomegalovirus colitis | Very frequent (80-99%) |
| HP:0000554 | Uveitis | Frequent (30-79%) |
| HP:0001287 | Meningitis | Frequent (30-79%) |
| HP:0001824 | Weight loss | Frequent (30-79%) |
| HP:0001945 | Fever | Frequent (30-79%) |
| HP:0002017 | Nausea and vomiting | Frequent (30-79%) |
| HP:0002027 | Abdominal pain | Frequent (30-79%) |
| HP:0002039 | Anorexia | Frequent (30-79%) |
| HP:0002090 | Pneumonia | Frequent (30-79%) |
| HP:0006515 | Interstitial pneumonitis | Frequent (30-79%) |
| HP:0012115 | Hepatitis | Frequent (30-79%) |
| HP:0012486 | Myelitis | Frequent (30-79%) |
| HP:0032118 | Retinitis | Frequent (30-79%) |
| HP:0033993 | Viral encephalitis | Frequent (30-79%) |
| HP:0430087 | Anti-cytomegalovirus antibody positivity | Frequent (30-79%) |
| HP:0000572 | Visual loss | Occasional (5-29%) |
| HP:0000979 | Purpura | Occasional (5-29%) |
| HP:0000988 | Skin rash | Occasional (5-29%) |
| HP:0001289 | Confusion | Occasional (5-29%) |
| HP:0001733 | Pancreatitis | Occasional (5-29%) |
| HP:0001873 | Thrombocytopenia | Occasional (5-29%) |
| HP:0001878 | Hemolytic anemia | Occasional (5-29%) |
| HP:0003326 | Myalgia | Occasional (5-29%) |
| HP:0004936 | Venous thrombosis | Occasional (5-29%) |
| HP:0012223 | Splenic rupture | Occasional (5-29%) |
| HP:0012378 | Fatigue | Occasional (5-29%) |
| HP:0025143 | Chills | Occasional (5-29%) |
| HP:0033117 | Duodenitis | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | idiopathic disseminated cytomegalovirus infection |
| Mondo ID | MONDO:0018108 |
| Orphanet | 35062 |
| UMLS | C5680152 |
| MedGen | 1826159 |
| GARD | 0018811 |
| Is cancer (heuristic) | no |
Also known as: idiopathic disseminated CMV infection
Disease family
This is a subtype of cytomegalovirus infection. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › primary viral infectious disease › Herpesviridae infectious disease › cytomegalovirus infection › idiopathic disseminated cytomegalovirus infection
Related subtypes (3): cytomegalovirus retinitis, fetal cytomegalovirus syndrome, cytomegalovirus pneumonia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.